Liraglutide Improves Non-Motor Function and Activities of Daily Living in Patients with Parkinson’s disease: A Randomized, Double-Blind, Placebo-Controlled Trial (P9-11.005)
Camille Malatt, Tina Wu, Catherine Bresee, Elliot Hogg, Jeffrey Wertheimer, Echo Tan, Hayley Pomeroy, Gloria Obialisi, Michele Tagliati
Abstract
To test the therapeutic efficacy and safety of the GLP-1 agonist liraglutide in patients with idiopathic PD.
Topics & Concepts
PlaceboMedicineMotor functionDouble blindParkinson's diseaseRandomized controlled trialPhysical therapyPhysical medicine and rehabilitationDiseaseInternal medicineAlternative medicinePathologyParkinson's Disease Mechanisms and Treatments